vs
Side-by-side financial comparison of BGC Group, Inc. (BGC) and Edwards Lifesciences (EW). Click either name above to swap in a different company.
Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $955.5M, roughly 1.7× BGC Group, Inc.). Edwards Lifesciences runs the higher net margin — 23.1% vs 8.4%, a 14.7% gap on every dollar of revenue. On growth, BGC Group, Inc. posted the faster year-over-year revenue change (43.8% vs 16.7%). Over the past eight quarters, BGC Group, Inc.'s revenue compounded faster (48.2% CAGR vs 9.7%).
BGC Group, Inc. is an American global financial services company based in New York City and London. Originally formed as part of the larger Cantor Fitzgerald organization, BGC Partners became its own entity in 2004.
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
BGC vs EW — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $955.5M | $1.6B |
| Net Profit | $80.6M | $380.7M |
| Gross Margin | — | 78.0% |
| Operating Margin | — | 1.8% |
| Net Margin | 8.4% | 23.1% |
| Revenue YoY | 43.8% | 16.7% |
| Net Profit YoY | — | 6.8% |
| EPS (diluted) | $0.17 | $0.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $955.5M | $1.6B | ||
| Q4 25 | $638.6M | $1.6B | ||
| Q3 25 | $620.8M | $1.6B | ||
| Q2 25 | $648.0M | $1.5B | ||
| Q1 25 | $534.6M | $1.4B | ||
| Q4 24 | $475.2M | $1.4B | ||
| Q3 24 | $448.9M | $1.4B | ||
| Q2 24 | $435.0M | $1.4B |
| Q1 26 | $80.6M | $380.7M | ||
| Q4 25 | $14.4M | $91.2M | ||
| Q3 25 | $27.9M | $291.1M | ||
| Q2 25 | $57.5M | $333.2M | ||
| Q1 25 | $55.2M | $358.0M | ||
| Q4 24 | $25.2M | $385.6M | ||
| Q3 24 | $14.7M | $3.1B | ||
| Q2 24 | $37.8M | $366.3M |
| Q1 26 | — | 78.0% | ||
| Q4 25 | — | 78.1% | ||
| Q3 25 | — | 77.8% | ||
| Q2 25 | — | 77.5% | ||
| Q1 25 | — | 78.7% | ||
| Q4 24 | — | 78.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 79.9% |
| Q1 26 | — | 1.8% | ||
| Q4 25 | 3.9% | 9.6% | ||
| Q3 25 | 5.4% | 19.8% | ||
| Q2 25 | 11.6% | 26.8% | ||
| Q1 25 | 15.0% | 27.9% | ||
| Q4 24 | 5.7% | 22.6% | ||
| Q3 24 | 4.4% | 25.9% | ||
| Q2 24 | 12.7% | 26.8% |
| Q1 26 | 8.4% | 23.1% | ||
| Q4 25 | 2.3% | 5.8% | ||
| Q3 25 | 4.5% | 18.7% | ||
| Q2 25 | 8.9% | 21.7% | ||
| Q1 25 | 10.3% | 25.3% | ||
| Q4 24 | 5.3% | 27.8% | ||
| Q3 24 | 3.3% | 226.7% | ||
| Q2 24 | 8.7% | 26.7% |
| Q1 26 | $0.17 | $0.66 | ||
| Q4 25 | $0.03 | $0.16 | ||
| Q3 25 | $0.06 | $0.50 | ||
| Q2 25 | $0.11 | $0.56 | ||
| Q1 25 | $0.11 | $0.61 | ||
| Q4 24 | $0.04 | $0.65 | ||
| Q3 24 | $0.03 | $5.13 | ||
| Q2 24 | $0.08 | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $781.0M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | — |
| Total Assets | $5.9B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $781.0M | — | ||
| Q4 25 | $851.5M | $4.2B | ||
| Q3 25 | $774.9M | $3.8B | ||
| Q2 25 | $827.8M | $4.1B | ||
| Q1 25 | $966.4M | $3.9B | ||
| Q4 24 | $711.6M | $4.0B | ||
| Q3 24 | $563.5M | $4.4B | ||
| Q2 24 | $571.7M | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $972.5M | $10.3B | ||
| Q3 25 | $965.3M | $10.2B | ||
| Q2 25 | $930.5M | $10.5B | ||
| Q1 25 | $963.8M | $10.1B | ||
| Q4 24 | $898.5M | $10.0B | ||
| Q3 24 | $860.1M | $9.5B | ||
| Q2 24 | $858.1M | $7.4B |
| Q1 26 | $5.9B | — | ||
| Q4 25 | $4.4B | $13.7B | ||
| Q3 25 | $5.8B | $13.3B | ||
| Q2 25 | $4.9B | $13.5B | ||
| Q1 25 | $4.9B | $13.0B | ||
| Q4 24 | $3.6B | $13.1B | ||
| Q3 24 | $4.4B | $13.0B | ||
| Q2 24 | $4.3B | $10.1B |
| Q1 26 | — | — | ||
| Q4 25 | 1.58× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 1.97× | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.68× | — | ||
| Q2 24 | 1.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BGC
| Commissions | $752.9M | 79% |
| Principal transactions | $142.9M | 15% |
| Data, network and post-trade | $34.5M | 4% |
| Other revenues | $10.3M | 1% |
| Fees from related parties | $4.3M | 0% |
EW
Segment breakdown not available.
